October 20, 2021 | 2:00 – 3:00 PM ET | Live Webinar For the New to Food and Drug Law Group Only
Tobacco Conference Primer Webinar
FDLI’s Tobacco and Nicotine Products Regulation and Policy Conference brings together a diverse group of stakeholders to discuss effectively regulating the broad spectrum of tobacco and nicotine products in the US. This webinar allows for New to Food and Drug Law members interested in this industry to learn from experts about the key topics and background information you need to fully understand the topics being covered.
ELIZABETH (LIZ) OESTREICH is Vice President, Regulatory Compliance at Greenleaf Health Inc., where she brings a diverse background of legal, public policy, and non-profit sector knowledge to her position. In her consultation of drug and medical device clients, she works to remediate compliance issues by reviewing Form 483 and warning letter responses, offering guidance on how to build a culture of quality within a company, and providing tips for communicating global quality improvements to FDA. In addition, she advises clients navigating the regulatory landscape for tobacco products and offers guidance on content and format of applications, interpretation of FDA regulation, communication with the FDA, and analysis of proposed rules. Ms. Oestreich also works with clients in the Cannabidiol space, offering strategic guidance and risk-based strategies as the FDA contemplates how to regulate the product category. Prior to joining Greenleaf Health, she served as Director of Educational Programming for the Food and Drug Law Institute (FDLI) in Washington, DC. While at FDLI, she gained extensive experience in all FDA-regulated product areas through regularly corresponding with FDA officials, as well as creating and supervising the development of curricula for an array of educational programs. She earned a BS in Political Science from the University of Arizona and a JD from the University of the District of Columbia’s David A. Clarke School of Law.
SCOTT BALLIN is a tobacco and health policy consultant in Washington, DC and has spent more than 30 years involved in issues related to tobacco and health. He was Vice President for Public Policy and Legislative Counsel at the American Heart Association and Chairman of the Coalition on Smoking OR Health. More recently, he served on the Steering Committee of the Alliance for Health Economic and Agriculture Development (AHEAD), an informal organization committed to bringing parties together to discuss controversial issues, remove barriers, foster constructive dialogue, and look for new opportunities to find common ground. He is currently serving as an advisor to the Institute for Environmental Negotiation at the University of Virginia in putting together a series of dialogues on harm reduction.
NATHAN A. BEATON is an associate at Latham & Watkins LLP where he focuses his practice on regulatory and transactional matters involving the healthcare and life sciences industries. Mr. Beaton counsels clients on matters involving the Food and Drug Administration (FDA), Department of Health & Human Services Office of Inspector General, Centers for Medicare & Medicaid Services, Federal Trade Commission, and other governmental authorities. Mr. Beaton has experience advising clients in all stages of the biotechnology product life cycle, including pre-market regulatory communications and submissions, contract matters relating to clinical trials, promotion and labeling, compliance with the Quality System Regulation and Good Manufacturing Practice requirements, reimbursement strategy, post-market inspections and recalls, and administrative appeals. He also advises financial institutions, healthcare providers and suppliers, and pharmaceutical, medical device, and biotechnology companies on healthcare and FDA regulatory matters in connection with mergers and acquisitions, equity offerings, financings, and other transactions. Mr. Beaton earned his Juris Doctor from the University of Chicago Law School, with honors, and his Master of Public Policy from the University of Chicago Harris School, with a Certificate in Health Policy. While in law school, he served as a legal intern at Ann & Robert H. Lurie Children’s Hospital, and participated in the Law School’s Corporate Lab, a transactional-focused legal clinic.